The first CRISPR therapy arrives in 2023: it will hit thalassemia and rare blood diseases
The first CRISPR gene editing application against thalassemia and other blood diseases will change the future of drug development.
The first CRISPR gene editing application against thalassemia and other blood diseases will change the future of drug development.
Alberto Robiati and Gianluca Riccio guide readers through scenarios of the future: the opportunities, risks and possibilities we have to create a possible tomorrow.
News about the world of tomorrow.
We give news about the future of technology, science and society: if there is one thing that is about to arrive, it has already arrived here.
Category
Language editions
© 2024 Near future - This work is distributed under license Creative Commons Attribution 4.0 International.